TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 34 filers reported holding TENAX THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $6,000 | -96.9% | 12,345 | -97.7% | 0.00% | – |
| Q3 2017 | $193,000 | -74.3% | 535,763 | -47.3% | 0.00% | – |
| Q2 2017 | $751,000 | +14.1% | 1,015,972 | -13.1% | 0.00% | – |
| Q1 2017 | $658,000 | -63.1% | 1,169,292 | +27.8% | 0.00% | – |
| Q4 2016 | $1,785,000 | -20.2% | 915,095 | -5.9% | 0.00% | – |
| Q3 2016 | $2,236,000 | -10.2% | 972,213 | 0.0% | 0.00% | – |
| Q2 2016 | $2,489,000 | +23.5% | 972,213 | -1.1% | 0.00% | – |
| Q1 2016 | $2,016,000 | -37.4% | 983,413 | +0.1% | 0.00% | – |
| Q4 2015 | $3,223,000 | +8.9% | 982,713 | +0.6% | 0.00% | – |
| Q3 2015 | $2,959,000 | -17.8% | 976,646 | +0.1% | 0.00% | – |
| Q2 2015 | $3,599,000 | +14.3% | 975,246 | +1.0% | 0.00% | – |
| Q1 2015 | $3,149,000 | -13.7% | 965,944 | +1.7% | 0.00% | – |
| Q4 2014 | $3,649,000 | +181.8% | 950,244 | +188.5% | 0.00% | – |
| Q3 2014 | $1,295,000 | – | 329,393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,108,593 | $3,326,000 | 1.32% |
| RA Capital Management | 2,670,300 | $8,011,000 | 1.15% |
| Opaleye Management Inc. | 635,000 | $1,905,000 | 0.94% |
| Broadfin Capital, LLC | 1,968,631 | $5,906,000 | 0.33% |
| SABBY MANAGEMENT, LLC | 2,604,660 | $7,892,000 | 0.32% |
| DAFNA Capital Management LLC | 81,509 | $245,000 | 0.24% |
| ARMISTICE CAPITAL, LLC | 88,739 | $266,000 | 0.09% |
| BOURGEON CAPITAL MANAGEMENT LLC | 17,500 | $52,000 | 0.04% |
| Verition Fund Management LLC | 25,640 | $78,000 | 0.02% |
| COMMERZBANK AKTIENGESELLSCHAFT /FI | 738,592 | $2,216,000 | 0.02% |